The next generation hepquant tests measure reduction in risk for clinical events in compensated nash cirrhosis subjects treated with resmetiromMichael P. Mcrae, Steve M. Helmke,Rebecca A. Taub, Gregory T. EversonHEPATOLOGY(2023)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要